CONMED Corporation (FRA:EC8)

Market Cap	1.00B -51.0%
Revenue (ttm)	1.17B +5.2%
Net Income	40.08M -64.5%
EPS	1.29 -64.5%
Shares Out	n/a
PE Ratio	24.97
Forward PE	8.96
Dividend	0.53 (1.54%)
Ex-Dividend Date	Sep 15, 2025

Volume	n/a
Average Volume	5
Open	34.20
Previous Close	34.40
Day's Range	34.20 - 34.20
52-Week Range	33.00 - 69.50
Beta	n/a
RSI	37.50
Earnings Date	Jan 28, 2026

About CONMED

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform mini...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1970
• Employees: 3,900
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: EC8

Financial Performance

In 2025, CONMED's revenue was $1.37 billion, an increase of 5.18% compared to the previous year's $1.31 billion. Earnings were $47.06 million, a decrease of -64.47%.

Financial numbers in USD